Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Sanofi .
Filed returns
8
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Sanofi | Health | to discuss the inclusion of HD vaccine in annual tenders (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2026 | Sanofi | Health | enhanced vaccines for influenza public health strategies (Public policy or programme) | 15 | On lobbying.ie |
| Sep–Dec 2025 | Sanofi | Health | Renhanced vaccines for influenza public health strategies (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2025 | Sanofi | Health | To make the case for the rollout of RSV immunisation programmes and better pandemic planning in Ireland, the EU and globally. (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2024 | Sanofi | Health | RSV implementation programme/Influenza immunisation (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2024 | Sanofi | Health | To make the case for a collaborative forum between the public and private sectors to allow co-operation on public health outcomes (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2024 | Sanofi | Health | To make the case for the rollout of RSV immunisation programmes and better pandemic planning in Ireland, the EU and globally. (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2018 | Sanofi | Health | The meeting was arranged to discuss the low level of influenza vaccination uptake in high risk populations in Ireland, particularly the over 65 year olds. The vaccination rate in Ireland is 55% vs a WHO target of 75%.… (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 8 | 100.0% |